Early Feasibility Study of the Edwards FORMA Tricuspid Transcatheter Repair System
Sponsor: Edwards Lifesciences
Listed as NCT02471807, this NA trial focuses on Tricuspid Valve Regurgitation and remains completed. Sponsored by Edwards Lifesciences, it has been updated 15 times since 2015, reflecting substantial change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.
Status Flow
Change History
15 versions recorded-
Sep 2024 — Present [monthly]
Completed NA
-
Jul 2024 — Sep 2024 [monthly]
Completed NA
-
Apr 2023 — Jul 2024 [monthly]
Completed NA
Status: Active Not Recruiting → Completed
-
Feb 2022 — Apr 2023 [monthly]
Active Not Recruiting NA
-
Jan 2021 — Feb 2022 [monthly]
Active Not Recruiting NA
▶ Show 10 earlier versions
-
Aug 2019 — Jan 2021 [monthly]
Active Not Recruiting NA
Status: Recruiting → Active Not Recruiting
-
Jul 2019 — Aug 2019 [monthly]
Recruiting NA
-
Jun 2019 — Jul 2019 [monthly]
Recruiting NA
-
May 2019 — Jun 2019 [monthly]
Recruiting NA
-
Feb 2019 — May 2019 [monthly]
Recruiting NA
-
Jun 2018 — Feb 2019 [monthly]
Recruiting NA
-
Apr 2018 — Jun 2018 [monthly]
Recruiting NA
-
Apr 2017 — Apr 2018 [monthly]
Recruiting NA
-
Feb 2017 — Apr 2017 [monthly]
Recruiting NA
-
Jan 2017 — Feb 2017 [monthly]
Recruiting NA
First recorded
Dec 2015
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Edwards Lifesciences
For direct contact, visit the study record on ClinicalTrials.gov .